Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

INAB

IN8bio (INAB)

IN8bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:INAB
DateTimeSourceHeadlineSymbolCompany
11/10/20214:15PMGlobeNewswire Inc.IN8bio Reports Third Quarter 2021 Financial Results and Provides Corporate UpdateNASDAQ:INABIN8bio Inc
11/04/20218:00AMGlobeNewswire Inc.IN8bio to Present at Scientific Conferences in November: PEGS Europe, SITC and SNONASDAQ:INABIN8bio Inc
10/27/20217:00AMGlobeNewswire Inc.IN8bio’s Announces Peer-Reviewed Publication of Preclinical Results Using Proprietary MGMT-modified Gamma-Delta T Cells (INB-200) with Temozolomide in Mouse Models of Glioblastoma MultiformeNASDAQ:INABIN8bio Inc
10/04/20214:15PMGlobeNewswire Inc.IN8bio to Present at BioFuture 2021 and Advanced Therapies Congress & Expo 2021NASDAQ:INABIN8bio Inc
09/10/20214:15PMGlobeNewswire Inc.IN8bio Reports Second Quarter 2021 Financial Results and Provides Corporate UpdateNASDAQ:INABIN8bio Inc
08/30/20217:00AMGlobeNewswire Inc.IN8bio to Present at the NewYorkBIO Virtual Breakfast Series and H.C. Wainwright 23rd Annual Global Investment ConferenceNASDAQ:INABIN8bio Inc
08/11/20218:00AMGlobeNewswire Inc.IN8bio Completes Dosing of First Cohort in Phase 1 Clinical Trial with Allogeneic Gamma Delta T-Cell Therapy in Leukemia Patients Undergoing Hematopoietic Stem Cell TransplantNASDAQ:INABIN8bio Inc
08/04/20218:00AMGlobeNewswire Inc.IN8bio Appoints Emily Fairbairn and Luba Greenwood to Board of DirectorsNASDAQ:INABIN8bio Inc
07/30/20217:00AMGlobeNewswire Inc.IN8bio Announces Pricing of Initial Public OfferingNASDAQ:INABIN8bio Inc
 Showing the most relevant articles for your search:NASDAQ:INAB